Form 4: Bausch + Lomb Director Nathalie Bernier Acquires Shares
Director Equity Grant
Director Nathalie D. Bernier acquired 15,842 common shares of Bausch + Lomb Corporation via an annual RSU grant.
Summary
- Director Nathalie D. Bernier received an annual grant of 15,842 restricted share units (RSUs).
- The transaction occurred on May 26, 2026, at a price of $15.78 per share.
- Following this transaction, the director's total beneficial ownership increased to 85,505 common shares.
- The RSUs were issued under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral, routine regulatory filing reflecting standard director compensation rather than a strategic shift or market-moving event.
Positives
- Increased alignment between director interests and shareholder value through equity ownership.
- Standard annual equity compensation grant indicates stable corporate governance practices.
Negatives
- None identified.
Risks
- Market price volatility of Bausch + Lomb common shares could impact the value of the director's holdings.
Future Outlook
The RSUs are scheduled to vest on the date immediately preceding the conclusion of the next annual meeting of shareholders.
Industry Context
StockSavvy.ai notes that annual equity grants to non-employee directors are a standard corporate governance practice in the pharmaceutical and medical device industry to ensure long-term alignment with shareholder interests.
Comparison to Industry Standards
- The grant of RSUs as part of director compensation is consistent with standard practices for large-cap healthcare companies.
- The structure of the 2022 Omnibus Incentive Plan aligns with typical equity incentive programs seen in peer companies like Alcon or CooperCompanies.
Stakeholder Impact
- Shareholders benefit from increased director 'skin in the game'.
Next Steps
- Vesting of the 15,842 RSUs prior to the next annual meeting of shareholders.
Key Dates
| Date | Description |
|---|---|
| 05/26/2026 | Date of the RSU grant transaction. |
| 05/28/2026 | Date the Form 4 was signed and filed. |
Keywords
Bausch + Lomb, BLCO, Insider Trading, Form 4, Equity Compensation, Director Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.